CEO of Dynamis Corporation
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Nobel Laureate, Professor of Biology, Caltech
Head of global research and development at Life Technologies
The National Cancer Institute recently introduced the Small Business Innovation Research (SBIR) Phase II Bridge Award mechanism, which is intended to offer an incentive to phase II awardees who obtain third party financing in order commercialize technologies developed with SBIR funds. Michael Weingarten, director of the SBIR Development Center at the National Cancer Institute, and program director Ali Andalibi will provide an overview of the program. Online registration is here.